Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours
- 30 June 2004
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (9), 1373-1382
- https://doi.org/10.1016/j.ejca.2004.01.038
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- ALCAM/CD166 is up‐regulated in low‐grade prostate cancer and progressively lost in high‐grade lesionsThe Prostate, 2002
- Elastase-mediated Release of Heparan Sulfate Proteoglycans from Pulmonary Fibroblast CulturesJournal of Biological Chemistry, 1999
- Functions of Cell Surface Heparan Sulfate ProteoglycansAnnual Review of Biochemistry, 1999
- Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcomeThe Journal of Pathology, 1998
- Regulated Shedding of Syndecan-1 and -4 Ectodomains by Thrombin and Growth Factor Receptor ActivationPublished by Elsevier ,1997
- Syndecan-1: A New Prognostic Marker in Laryngeal CancerActa Oto-Laryngologica, 1997
- Expression of syndecan-1 changes during the differentiation of visceral and parietal endoderm from murine F9 teratocar Cinoma cellsDifferentiation, 1995
- Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells.Molecular Biology of the Cell, 1995
- Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns.Molecular Biology of the Cell, 1994
- Phenotypic features of stromal cells in normal, premalignant and malignant conditionsEuropean Journal Of Cancer, 1992